SCHEMBL31731468

SCHEMBL31731468

COC(=O)/C=C(\C)c1ccc2c(-c3ccccc3C)ccnc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CSNK2A2 P19784 1/20 0.38
▸ CSNK2B P67870 1/20 0.38
▸ PLA2G7 Q13093 1/20 0.37
▸ F2 P00734 2/20 0.37
▸ PLG P00747 2/20 0.37
▸ PRSS1 P07477 2/20 0.37
▸ SCN9A Q15858 3/20 0.36
▸ TLR8 Q9NR97 3/20 0.36
▸ NUDT1 P36639 1/20 0.36
▸ ALOX15 P16050 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31731754 0.83 ALOX15 (0.49) KDM5AKDM4CKDM5BMEN1KMT2A
SCHEMBL31731771 0.79 PLK1 (0.49) KDM5AKDM4CKDM5BMEN1KMT2A
SCHEMBL31731727 0.78 KDM5A (0.45) KDM5AKDM4CKDM5BMEN1KMT2A
SCHEMBL9907404 0.76 ALOX15 (0.52) KDM5AKDM4CKDM5BMEN1KMT2A
SCHEMBL31731738 0.76 GPBAR1 (0.46) KDM5AKDM4CKDM5BCSNK2A2CSNK2B
SCHEMBL30228312 0.75 KCNA3 (0.46) KMT2AALDH1A1CYP1A2
SCHEMBL31731473 0.74 TGFBR1 (0.50) KDM5AKDM4CKDM5BMEN1KMT2A
SCHEMBL31731728 0.73 ALDH1A1 (0.52) MEN1KMT2AALDH1A1CYP1A2HTT
SCHEMBL31731723 0.73 PLA2G7 (0.53) MEN1KMT2APLA2G7ALDH1A1MAPK1
SCHEMBL9907406 0.72 KDM4C (0.52) KDM5AKDM4CKDM5BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353816-A1 QUINOLINES AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353816-A1 QUINOLINES AS MODULATORS OF POLRMT POLRMT, POLM, TFAM KDM5A 2220/4885KDM4C 2176/4885KDM5B 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback